You are here:
HomeProductsCanagliflozin;JNJ 24831754ZAE; JNJ 28431754; JNJ 28431754AAA; TA 7284
Canagliflozin;JNJ 24831754ZAE; JNJ 28431754; JNJ 28431754AAA; TA 7284
-
- Product NameCanagliflozin;JNJ 24831754ZAE; JNJ 28431754; JNJ 28431754AAA; TA 7284
- CAS No.842133-18-0
- Purity>98%
- Min Quantity
- Price~
- View Contact Detail
Detailed Description
Canagliflozin(JNJ 24831754ZAE; JNJ 28431754; JNJ 28431754AAA; TA 7284) is an experimental drug being developed by Johnson & Johnson for the treatment of type 2 diabetes.Canagliflozin(JNJ 24831754ZAE; JNJ 28431754; JNJ 28431754AAA; TA 7284) is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter causes blood glucose to be eliminated through the urine.
http://www.chemscene.com/Canagliflozin.html